RICT 2015<br />Drug Discovery and Selection

The scientific programme of RICT 2015 is now available on the website!

Conferences > Archives > RICT 2015
Wednesday July 1, 2015
10:00Registration as of 10:00
11:00Elsevier Reaxys Workshop:
Data-Driven Approaches to Medicinal Chemistry: How Large-Scale Normalized Data Empowers Drug Discovery (duration: 90-minutes)
12:00Lunch bag (included in the fee, but subject to prior registration)
13:15Welcome Address
Dr Christine CONTINO-PEPIN (UNIVERSITY OF AVIGNON, Avignon, France)
Prof. Philippe OBERT (UNIVERSITY OF AVIGNON, Avignon, France)
Prof. Janos SAPI (SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France)
Session 1: Paul Ehrlich Award Lecture
Sponsored by Janssen-Cilag
Session Chairs
Prof. Janos SAPI (SCT & UNIVERSITY OF REIMS-CHAMPAGNE-ARDENNE, Reims, France)
Dr Oscar DELGADO (JANSSEN R&D, Toledo, Spain)
13:30Paul Ehrlich Awardee - The Synthetic Peptide P140, a Skilled Strategist and Manipulator of the Immune System
Dr Sylviane MULLER
(IBMC-CNRS, Strasbourg, France)
Session 2: Kinases & Oncology
Sponsored by Servier
Session Chair
Dr Olivier MIRGUET
(INSTITUT DE RECHERCHES SERVIER, Suresnes, France)
14:30Discovery and Characterisation of Potent and Selective Inhibitors of ATR Kinase as Anti-cancer Agents
Mr Jean-Damien CHARRIER
(VERTEX PHARMACEUTICALS, OXON, United Kingdom)
15:15Covalent Kinase Inhibitors: A Practical Guide to Molecular Trapping
Dr Tjeerd BARF
(ACERTA PHARMA BV, Oss, The Netherlands)
16:00Coffee Break & Exhibition
Session 3: Resistance in Infectious Diseases
Session Chair
Dr Hong SHEN
(ROCHE INNOVATION CENTER, Shanghai, China)
16:30Antibiotic Resistance is an Emerging Disease
Dr Patrice COURVALIN
(INSTITUT PASTEUR, Paris, France)
17:15Resistance Phenotypes and SAR in HCV Drug Development
Dr John BILELLO
(MERCK, Whitehouse Station, United States)
18:00Welcome Reception
19:30End of the Welcome Reception
Thursday July 2, 2015
Session 4: Tools for Cell Therapy
Session Chair
Dr Pascal GEORGE
(SCT & INDEPENDENT SCIENTIFIC EXPERT & ADVISER, Longvilliers, France)
08:30Synthetic Molecules for Cell Biology and Cell Therapy
Prof. Motonari UESUGI
(KYOTO UNIVERSITY, Kyoto, Japan)
Session 5: Short Communications - Targeting Apoptosis
Sponsored by SCT
Session 6: Short Communications - CNS Diseases
Sponsored by SCT
Session Chair
Prof. Muriel AMBLARD
(CNRS-UNIVERSTY OF MONTPELLIER I, Montpellier, France)
09:30How do a Proapoptotic and a Cell Penetration Peptide work Together to kill Cancer Cells?
Dr Isabel ALVES
(UNIVERSITY OF BORDEAUX, Pessac, France)
10:00Allosteric Inhibitors of p38 MAPK-MK2 Pathway for Selective Cancer Cell Killing
Dr Lenka MUNOZ
(UNIVERSITY OF SYDNEY, Sydney, Australia)
Session Chair
Dr Grégory DURAND
(UNIVERSITY OF AVIGNON, Avignon, France)
09:30Development of Novel Multi-Target Directed Ligands for Alzheimer's Disease: Identification of Donecopride
Prof. Christophe ROCHAIS
(UNIVERSITY OF CAEN, Caen, France)
10:00Development of Unnatural Basic Amino Acids Leading to Orally-Active NPFF Receptor Antagonists Preventing Opioid-Induced Hyperalgesia during the Treatment of Acute or Chronic Pains
Dr Frédéric BIHEL
(CNRS / UNIVERSITY OF STRASBOURG, Illkirch, France)
10:30Coffee Break & Exhibition
Session 7: DiabetesSession 8: Tools for Target ID
Session Chair
Dr Alessandra NURISSO
(UNIVERSITY OF GENEVA, Genève, Switzerland)
11:15From in situ Click to in vivo: Effect of Inhibition of Insulin Degrading Enzyme
Prof. Rebecca DEPREZ-POULAIN
(UNIVERSITY OF LILLE, Lille, France)
12:00Revolutionary Idea Yielded SGLT2 Inhibitor Canagliflozin for Treatment of Type 2 Diabetes
Dr Sumihiro NOMURA
(MITSUBISHI TANABE PHARMA CORPORATION, Saitama, Japan)
Session Chair
Prof. Sun CHOI
(EWHA WOMANS UNIVERSITY, Seoul, Korea, South)
11:15Retinoids/Steroids as Ligands for Pharmacological Chaperon and Protein Knockdown Approach
Prof. Yuichi HASHIMOTO
(THE UNIVERSITY OF TOKYO, Tokyo, Japan)
12:00Chemical Probes for Epigenetic Proteins
Prof. Paul BRENNAN
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)
12:45Lunch & Exhibition
13:30Poster Session 1
(posters with odd numbers)
13:45Career Session
Session 9: Cardiac DiseasesSession 10: Structure Based Approaches
Sponsored by 'Fondation de la Maison de la Chimie'
Session Chair
Prof. Joachim MITTENDORF
(BAYER PHARMA AG, Wuppertal, Germany)
14:45Phenotypic Screening for the Discovery of Novel Molecules for Therapeutic Cardiac Regeneration
Dr Alleyn T. PLOWRIGHT
(ASTRAZENECA, Cambridge, United Kingdom)
15:30BAY 1067197 - Discovery of a Partial Adenosine A1 Agonist for the Treatment of Heart Failure
Dr Daniel MEIBOM
(BAYER PHARMA, Wuppertal, Germany)
Session Chair
Dr Jean-Paul RENAUD
(RIBOSTRUCT, Ostwald, France)
14:45Drugs, Targets, Diseases and the Druggable Proteome
Prof. Tudor I. OPREA
(UNIVERSITY OF NEW MEXICO, Albuquerque, United States)
15:30Shedding Light on Protein Kinase Plasticity
Prof. Pascal BONNET
(UNIVERSITY OF ORLÉANS, Orléans, France)
16:15Coffee Break & Exhibition
Session 11: Neglected/Rare DiseasesSession 12: GPCRs
Session Chair
Dr Anne VALADE
(UCB, Braine-l'Alleud, Belgium)
16:45Lessons learned in TB Drug Discovery
Dr Jan JIRICEK
(NOVARTIS INSTITUTE FOR TROPICAL DISEASES, Singapore, Singapore)
17:30Cerdelga, an Oral Therapy for Gaucher’s Disease; from Discovery to Launch
Dr David J HARRIS
(SANOFI, Waltham, United States)
Session Chair
Dr Manuel CASES-THOMAS
(ELI LILLY & COMPANY, United Kingdom)
16:45Two Steps Forward, One Step Back: Successes and Failures in Structure-based Discovery of GPCR Ligands
Prof. Jens CARLSSON
(STOCKHOLM UNIVERSITY, Stockholm, Sweden)
17:30Fragment and Structure-Based Drug Discovery for a Family C GPCR: Discovery of the mGlu5 NAM Pre-clinical Candidate HTL14242
Dr John CHRISTOPHER
(HEPTARES, Hertfordshire, United Kingdom)
20:00Symposium Banquet
Friday July 3, 2015
Session 13: Viral Diseases
Sponsored by IDENIX an MSD Company
Session Chair
Dr Sylvie POCHET
(INSTITUT PASTEUR, Paris, France)
08:30Sofosbuvir: A Breakthrough Curative Therapy for HCV
Dr Michael SOFIA
(TEKMIRA/ONCORE BIOPHARMA, Doylestown, PA, United States)
09:15Discovery of HIV Integrase Inhibitors
Dr John WAI
(WUXI APPTEC, Shanghai, China)
10:00Coffee Break & Exhibition
10:30Poster Session 2
(posters with even numbers)
Session 14: Pierre Fabre Award Lecture
Sponsored by Pierre Fabre
Session Chair
Dr Serge GRISONI
(CENTRE DE RECHERCHE ET DÉVELOPPEMENT PIERRE FABRE, Toulouse, France)
11:45Pierre Fabre Awardee - Small Molecules, Big Players
Dr Raphaël RODRIGUEZ
(INSTITUT CURIE, Paris, France)
12:30Lunch & Exhibition
Session 15: Immuno/Inflammatory Diseases
Sponsored by GSK
Session Chair
Dr Alexis DENIS
(GSK, Courtaboeuf, France)
13:30Novel Triazolopyridine Compounds as Selective JAK1 Inhibitors: From Target Discovery to Filgotinib
Dr Christel MENET
(GALAPAGOS, Brussels, Belgium)
14:15Locking the Bioactive Conformation – Discovery of BAY 85-8501, a Potent Inhibitor of Human Neutrophil Elastase
Dr Franz VON NUSSBAUM
(BAYER PHARMA, Berlin, Germany)
Session 16: Poster Prizes and Closing Remarks
Session Chair
Dr Luc VAN HIJFTE
(SCT & NOVALIX, Nijmegen, The Netherlands)
15:00Poster Prizes & Closing Remarks
Session 17: Future Event and Closing
Session Chair
Prof. Patrick DALLEMAGNE
(UNIVERSITY OF CAEN, Caen, France)
15:15Introduction to RICT 2016
15:30End of the symposium

Copyright 2021 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys